Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes

被引:78
作者
Fujisawa, Keiko [1 ]
Katakami, Naoto [1 ,2 ]
Kaneto, Hideaki [1 ]
Naka, Toyoko [1 ]
Takahara, Mitsuyoshi [1 ]
Sakamoto, Fumie [1 ]
Irie, Yoko [1 ]
Miyashita, Kazuyuki [1 ]
Kubo, Fumiyo [1 ]
Yasuda, Tetsuyuki [1 ]
Matsuoka, Taka-aki [1 ]
Shimomura, Iichiro [1 ]
机构
[1] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Metab & Atherosclerosis, Grad Sch Med, Suita, Osaka 5650871, Japan
关键词
sRAGE; RAGE; Cardiovascular event; Atherosclerosis; Type; 2; diabetes; GLYCATION END-PRODUCTS; CORONARY-ARTERY-DISEASE; ENDPRODUCTS RAGE; RECEPTOR; ATHEROSCLEROSIS; ASSOCIATION; SRAGE; FORM;
D O I
10.1016/j.atherosclerosis.2013.01.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is still controversial whether circulating soluble form of receptor for AGE (sRAGE) is associated with atherosclerosis in diabetic patients. In this study, we enrolled 276 Japanese type 2 diabetic subjects without history of cardiovascular disease (CVD), assessed their baseline clinical and biochemical data including serum sRAGE levels, and prospectively evaluated the association between these parameters and CVD events. The median follow-up period was 5.6 years and there were 25 new CVD events. The tertile analysis showed that the risk for CVD events was higher as serum sRAGE levels were increased (p for trend = 0.046). A multivariate Cox proportional hazards regression analysis revealed that serum sRAGE levels were independently associated with CVD (HR per 1SD = 1.59, 95% CI 1.04-2.45, p = 0.034), even after adjusting for conventional coronary risk factors. In summary, elevated sRAGE levels were associated with the increased risk of CVD in Japanese type 2 diabetic subjects. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 50 条
  • [21] Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes
    Miranda, Edwin R.
    Somal, Vikram S.
    Mey, Jacob T.
    Blackburn, Brian K.
    Wang, Edward
    Farabi, Sarah
    Karstoft, Kristian
    Fealy, Ciaran E.
    Kashyap, Sangeeta
    Kirwan, John P.
    Quinn, Laurie
    Solomon, Thomas P. J.
    Haus, Jacob M.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2017, 313 (06): : E631 - E640
  • [22] Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes
    Tan, Kathryn C. B.
    Cheung, Ching-Lung
    Lee, Alan C. H.
    Lam, Joanne K. Y.
    Wong, Ying
    Shiu, Sammy W. M.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (02)
  • [23] Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)
    Yokoyama, H.
    Araki, S.
    Kawai, K.
    Hirao, K.
    Oishi, M.
    Sugimoto, K.
    Sone, H.
    Maegawa, H.
    Kashiwagi, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) : 485 - 492
  • [24] Obesity Genotype Score and Cardiovascular Risk in Women With Type 2 Diabetes Mellitus
    He, Meian
    Cornelis, Marilyn C.
    Franks, Paul W.
    Zhang, Cuilin
    Hu, Frank B.
    Qi, Lu
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) : 327 - U370
  • [25] Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients
    Bansal, Savita
    Chawla, Diwesh
    Banerjee, Basu Dev
    Madhu, Sri Venkata
    Tripathi, Ashok Kumar
    GENE, 2013, 526 (02) : 325 - 330
  • [26] Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients
    Motawi, Tarek M. K.
    Abou-Seif, Mohamed A.
    Bader, Ahmed M. A.
    Mahmoud, Mohamed O.
    BMC ENDOCRINE DISORDERS, 2013, 13
  • [27] Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus
    Chen, Zeng
    Hong, Qiao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Kidney function and the risk of cardiovascular disease in patients with type 2 diabetes
    Wang, Yujie
    Katzmarzyk, Peter T.
    Horswell, Ronald
    Zhao, Wenhui
    Johnson, Jolene
    Hu, Gang
    KIDNEY INTERNATIONAL, 2014, 85 (05) : 1192 - 1199
  • [29] Predictor for cardiovascular risk in patients with type-2 diabetes mellitus
    Azharuddin, Md
    Kapur, Prem
    Mishra, Ritu
    Saleem, Shakir
    Gupta, Ashok Kumar
    Adil, Mohammad
    Sharma, Manju
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [30] Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
    Nowak, Christoph
    Carlsson, Axel C.
    Ostgren, Carl Johan
    Nystrom, Fredrik H.
    Alam, Moudud
    Feldreich, Tobias
    Sundstrom, Johan
    Carrero, Juan-Jesus
    Leppert, Jerzy
    Hedberg, Par
    Henriksen, Egil
    Cordeiro, Antonio C.
    Giedraitis, Vilmantas
    Lind, Lars
    Ingelsson, Erik
    Fall, Tove
    Arnlov, Johan
    DIABETOLOGIA, 2018, 61 (08) : 1748 - 1757